Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Budd-Chiari syndrome.

Michael A Zimmerman1, Andrew M Cameron, R Mark Ghobrial

  • 1Division of Liver and Pancreas Transplantation, Department of Surgery, The Pfleger Liver Institute, The Dumont-UCLA Transplant Center, The David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA 90095, USA.

Clinics in Liver Disease
|September 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver Cancer.

Liver cancer·2026
Same author

Voriconazole Dosing and Therapeutic Drug Monitoring in Patients Before and After Liver Transplantation.

Pharmacotherapy·2026
Same author

Graft survival after liver transplantation using portable normothermic machine perfusion at a US center.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same author

Evaluating the impact of neighborhood socioenvironmental burden on patient characteristics and survival in liver transplant recipients.

Frontiers in transplantation·2026
Same author

Cell cycle pathway alterations predict outcomes post-liver transplantation for hepatocellular carcinoma.

Frontiers in transplantation·2026
Same author

Liver transplantation in patients with history of extra-hepatic malignancies.

Frontiers in transplantation·2026
Same journal

Metabolic Dysfunction-Associated Steatohepatitis: From Fibrosis-Based Risk Stratification to Emerging Therapeutic Strategies.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease and Viral Hepatitis.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction Associated Steatohepatitis (MASH) in Oceania, Central America, and the Caribbean.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Latin America.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Africa: From Burden to Action.

Clinics in liver disease·2026
Same journal

Metabolic Dysfunction-Associated Steatotic Liver Disease in Asia: Epidemiology, Clinical Features, and Management.

Clinics in liver disease·2026
See all related articles

Budd-Chiari syndrome (BCS) involves hepatic venous outflow occlusion due to anatomical issues or clotting disorders. Diagnosis and supportive care are key, with surgical shunting and liver transplantation offering viable treatment options.

Area of Science:

  • Hepatology
  • Vascular Medicine
  • Gastroenterology

Background:

  • Budd-Chiari syndrome (BCS) is characterized by hepatic venous outflow occlusion.
  • It encompasses anatomical abnormalities and hypercoagulable disorders.
  • Common symptoms include hepatomegaly, abdominal pain, and ascites.

Purpose of the Study:

  • To outline the diagnostic approach for Budd-Chiari syndrome.
  • To review supportive medical therapies for BCS.
  • To evaluate surgical shunting and liver transplantation as treatment options.

Main Methods:

  • Review of clinical manifestations.
  • Analysis of diagnostic strategies.
  • Evaluation of treatment data for surgical and transplant options.

Related Experiment Videos

Main Results:

  • Budd-Chiari syndrome presents with varied clinical signs.
  • Medical management focuses on supportive care.
  • Surgical shunting and liver transplantation show promise.

Conclusions:

  • Effective management of Budd-Chiari syndrome requires accurate diagnosis and tailored therapy.
  • Surgical interventions and liver transplantation are critical treatment modalities for BCS.
  • Further research can optimize outcomes for patients with hepatic venous outflow obstruction.